Effects of magnesium and related divalent metal ions in topoisomerase structure and function

The catalytic steps through which DNA topoisomerases produce their biological effects and the interference of drug molecules with the enzyme–DNA cleavage complex have been thoroughly investigated both from the biophysical and the biochemical point of view. This provides the basic structural insight on how this family of essential enzymes works in living systems and how their functions can be impaired by natural and synthetic compounds. Besides other factors, the physiological environment is known to affect substantially the biological properties of topoisomerases, a key role being played by metal ion cofactors, especially divalent ions (Mg2+), that are crucial to bestow and modulate catalytic activity by exploiting distinctive chemical features such as ionic size, hardness and characteristics of the coordination sphere including coordination number and geometry. Indeed, metal ions mediate fundamental aspects of the topoisomerase-driven transphosphorylation process by affecting the kinetics of the forward and the reverse steps and by modifying the enzyme conformation and flexibility. Of particular interest in type IA and type II enzymes are ionic interactions involving the Toprim fold, a protein domain conserved through evolution that contains a number of acidic residues essential for catalysis. A general two-metal ion mechanism is widely accepted to account for the biophysical and biochemical data thus far available.

[1]  Sandra J. Aedo,et al.  Inhibition of Mg2+ binding and DNA religation by bacterial topoisomerase I via introduction of an additional positive charge into the active site region , 2008, Nucleic acids research.

[2]  C. Klee,et al.  Calcium as a cellular regulator , 1999 .

[3]  S. Kerwin,et al.  Synthesis, metal ion binding, and biological evaluation of new anticancer 2-(2'-hydroxyphenyl)benzoxazole analogs of UK-1. , 2008, Bioorganic & medicinal chemistry.

[4]  G. Capranico,et al.  Anthracyclines: selected new developments. , 2001, Current medicinal chemistry. Anti-cancer agents.

[5]  H. Hiasa The Glu-84 of the ParC subunit plays critical roles in both topoisomerase IV-quinolone and topoisomerase IV-DNA interactions. , 2002, Biochemistry.

[6]  Y. Tse‐Dinh,et al.  Mechanistic studies on E. coli DNA topoisomerase I: divalent ion effects. , 1991, Journal of inorganic biochemistry.

[7]  Y. Tse‐Dinh,et al.  Cleavage of dT8 and dT8 phosphorothioyl analogues by Escherichia coli DNA topoisomerase I: product and rate analysis. , 1988, Biochemistry.

[8]  N. Osheroff Eukaryotic topoisomerase II. Characterization of enzyme turnover. , 1986, The Journal of biological chemistry.

[9]  M. Palumbo,et al.  DNA gyrase requires DNA for effective two-site coordination of divalent metal ions: further insight into the mechanism of enzyme action. , 2008, Biochemistry.

[10]  M. Palumbo,et al.  The quinolone family: from antibacterial to anticancer agents. , 2003, Current medicinal chemistry. Anti-cancer agents.

[11]  M. Palumbo,et al.  The effects of metal ions on the structure and stability of the DNA gyrase B protein. , 2005, Journal of molecular biology.

[12]  Y. Tse‐Dinh,et al.  Mutation adjacent to the active site tyrosine can enhance DNA cleavage and cell killing by the TOPRIM Gly to Ser mutant of bacterial topoisomerase I , 2007, Nucleic acids research.

[13]  Jae Young Lee,et al.  Making and breaking nucleic acids: two-Mg2+-ion catalysis and substrate specificity. , 2006, Molecular cell.

[14]  T. Ceska,et al.  A helical arch allowing single-stranded DNA to thread through T5 5'-exonuclease , 1996, Nature.

[15]  Y. Tse‐Dinh Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases. , 2007, Infectious disorders drug targets.

[16]  G. Ireton,et al.  Biochemical and Biophysical Analyses of Recombinant Forms of Human Topoisomerase I (*) , 1996, The Journal of Biological Chemistry.

[17]  J. Cowan,et al.  Mechanism of metal-promoted catalysis of nucleic acid hydrolysis by Escherichia coli ribonuclease H , 1996, JBIC Journal of Biological Inorganic Chemistry.

[18]  Robert J.P. Williams,et al.  The Biological Chemistry of the Elements: The Inorganic Chemistry of Life , 2001 .

[19]  Y. Tse‐Dinh,et al.  Effect of Mg(II) Binding on the Structure and Activity ofEscherichia coli DNA Topoisomerase I* , 1997, The Journal of Biological Chemistry.

[20]  K. West,et al.  Mutagenesis of E477 or K505 in the B' domain of human topoisomerase II beta increases the requirement for magnesium ions during strand passage. , 2000, Biochemistry.

[21]  J. Koeller,et al.  Mitoxantrone: a novel anthracycline derivative. , 1988, Clinical pharmacy.

[22]  S. Mukhopadhyay,et al.  Bacterial Cell Killing Mediated by Topoisomerase I DNA Cleavage Activity* , 2005, Journal of Biological Chemistry.

[23]  A. Jeltsch,et al.  Structure and function of type II restriction endonucleases. , 2001, Nucleic acids research.

[24]  Wei Yang,et al.  An equivalent metal ion in one- and two-metal-ion catalysis , 2008, Nature Structural &Molecular Biology.

[25]  J. Cowan,et al.  Structural and catalytic roles for divalent magnesium in nucleic acid biochemistry , 2002, Biometals.

[26]  G. S. Manning The molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides , 1978, Quarterly Reviews of Biophysics.

[27]  S. Shuman,et al.  Mechanistic plasticity of DNA topoisomerase IB: phosphate electrostatics dictate the need for a catalytic arginine. , 2005, Structure.

[28]  D. Williams,et al.  The Biological Chemistry of the Elements , 1991 .

[29]  J. Perona,et al.  DNA cleavage by EcoRV endonuclease: two metal ions in three metal ion binding sites. , 2004, Biochemistry.

[30]  J. Steitz,et al.  A general two-metal-ion mechanism for catalytic RNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  N. Cozzarelli,et al.  The binding of gyrase to DNA: analysis by retention by nitrocellulose filters. , 1982, Nucleic acids research.

[32]  N. Osheroff,et al.  Human topoisomerase IIα uses a two-metal-ion mechanism for DNA cleavage , 2008, Nucleic acids research.

[33]  J. Tainer,et al.  Three Metal Ions Participate in the Reaction Catalyzed by T5 Flap Endonuclease* , 2008, Journal of Biological Chemistry.

[34]  Charles W. Bock,et al.  Manganese as a Replacement for Magnesium and Zinc: Functional Comparison of the Divalent Ions , 1999 .

[35]  N. Osheroff Role of the divalent cation in topoisomerase II mediated reactions. , 1987, Biochemistry.

[36]  G. Charles Dismukes,et al.  Manganese Enzymes with Binuclear Active Sites. , 1996, Chemical reviews.

[37]  James C. Wang,et al.  Identification of Active Site Residues in Escherichia coli DNA Topoisomerase I* , 1998, The Journal of Biological Chemistry.

[38]  M. Markowitz,et al.  Raltegravir (MK-0518): an integrase inhibitor for the treatment of HIV-1. , 2007, Drugs of today.

[39]  C. Schein,et al.  A “moving metal mechanism” for substrate cleavage by the DNA repair endonuclease APE‐1 , 2007, Proteins.

[40]  A. Mildvan,et al.  Vaccinia DNA topoisomerase I: single-turnover and steady-state kinetic analysis of the DNA strand cleavage and ligation reactions. , 1994, Biochemistry.

[41]  L. Liu,et al.  Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. , 1984, Cancer research.

[42]  J. Berger,et al.  DNA topoisomerases: harnessing and constraining energy to govern chromosome topology , 2008, Quarterly Reviews of Biophysics.

[43]  J. Cowan Structural and catalytic chemistry of magnesium-dependent enzymes , 2002, Biometals.

[44]  T. Mueser,et al.  Structure of Bacteriophage T4 RNase H, a 5′ to 3′ RNA–DNA and DNA–DNA Exonuclease with Sequence Similarity to the RAD2 Family of Eukaryotic Proteins , 1996, Cell.

[45]  A. Maxwell,et al.  The role of GyrB in the DNA cleavage-religation reaction of DNA gyrase: a proposed two metal-ion mechanism. , 2002, Journal of molecular biology.

[46]  L. Hurley,et al.  Structural Insight into a Quinolone-Topoisomerase II-DNA Complex , 1999, The Journal of Biological Chemistry.

[47]  J. Cowan,et al.  Metal Activation of Enzymes in Nucleic Acid Biochemistry. , 1998, Chemical reviews.

[48]  Y. Tse‐Dinh Bacterial and archeal type I topoisomerases. , 1998, Biochimica et biophysica acta.

[49]  Carmay Lim,et al.  Mononuclear versus binuclear metal-binding sites: metal-binding affinity and selectivity from PDB survey and DFT/CDM calculations. , 2008, Journal of the American Chemical Society.

[50]  J. Berger,et al.  Structural basis for gate-DNA recognition and bending by type IIA topoisomerases , 2007, Nature.

[51]  J. Kuriyan,et al.  A TOPRIM domain in the crystal structure of the catalytic core of Escherichia coli primase confirms a structural link to DNA topoisomerases. , 2000, Journal of molecular biology.

[52]  H. Bremer,et al.  Winding of the DNA helix by divalent metal ions. , 1997, Nucleic acids research.

[53]  Janet M. Thornton,et al.  Metal ions in biological catalysis: from enzyme databases to general principles , 2008, JBIC Journal of Biological Inorganic Chemistry.

[54]  K. Marx,et al.  A gel electrophoresis study of the competitive effects of monovalent counterion on the extent of divalent counterions binding to DNA. , 1998, Biophysical journal.

[55]  S. Shuman,et al.  Catalytic mechanism of DNA topoisomerase IB. , 2000, Molecular cell.

[56]  S. Halford,et al.  Divalent metal ions at the active sites of the EcoRV and EcoRI restriction endonucleases. , 1995, Biochemistry.

[57]  Y. Tse‐Dinh,et al.  The Acidic Triad Conserved in Type IA DNA Topoisomerases Is Required for Binding of Mg(II) and Subsequent Conformational Change* , 2000, The Journal of Biological Chemistry.

[58]  Detlef D. Leipe,et al.  Toprim--a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins. , 1998, Nucleic acids research.

[59]  Chonghui Cheng,et al.  Conservation of Structure and Mechanism between Eukaryotic Topoisomerase I and Site-Specific Recombinases , 1998, Cell.

[60]  A. Pingoud,et al.  Type II restriction endonucleases: structure and mechanism , 2005, Cellular and Molecular Life Sciences.

[61]  J. Champoux DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.

[62]  J. Wang,et al.  DNA topoisomerases: why so many? , 1991, The Journal of biological chemistry.

[63]  Weiguo Cao,et al.  Catalytic mechanism of endonuclease v: a catalytic and regulatory two-metal model. , 2006, Biochemistry.

[64]  J. Wang,et al.  Structural similarities between topoisomerases that cleave one or both DNA strands. , 1998, Proceedings of the National Academy of Sciences of the United States of America.